There are several problems associated with the homotransplantation of tissue in man, not least of which is the homograft rejection mechanism. Certainly with kidney transplantation the technical problems of implantation appear subservient to those concerned with the rejection phenomenon.
The role of lymphocytes in this immune response is not fully understood, but there is ample evidence of their special importance (Woodruff, 1960) . Loss of lymphocytes from the thoracic duct in rats resulted in severe depression or abolition of the primary immune response (McGregor and Gowans, -1963) , and multiple methods of producing lymphocyte reduction have been used as a means of prolonging homograft survival in both experimental animals and man.
Over the past four years we have been particularly interested in the treatment of melanoma with endolymphatic 1311 Lipiodol. Before this period lymph-node metastases from melanoma had been treated with endolymphatic 198Au (Jantet et al., 1964) .
Complete records have been made in a series of 50 patients who received endolymphatic 131I therapy for melanoma. These investigations included preoperative and postoperative leucocyte estimations. It was noted in our early investigations that the endolymphatic therapy in the range of dosages used did not depress the total leucocyte count markedly, though this did occur in the occasional patient. However, of more significance was the feature that in several patients a relative and absolute lymphopenia occurred. This paper is concerned with a detailed analysis of these patients, with particular reference to the achievement of a relatiVe and absolute lymphocyte depression after endolymphatic therapy.
Treatment Policy for Melanoma
Our therapeutic approach to the patient with malignant melanoma is to follow the initial wide excision of the primary lesion with endolymphatic therapy via the lymphatics draining the site of excision. The endolymphatic treatment is usually given three weeks after the time of excision, though when the diagnosis is assured synchronous treatment is occasionally given.
Should the lymph nodes be clinically and radiologically negative then this plan of action is usually regarded as sufficient, and the patient is subsequently followed carefully in the outpatient department. In some patients node dissections have been made at varying intervals after endolymphatic treatment. Microscopical examination often reveals total destruction of lymph nodes in this group (see Fig. 1 However, regional nodes adjudged clinically and radiologically positive with respect to metastases always require further treatment (see Fig. 2 ). This is due to the short penetration of the fi-particle of "31I in tissue (see Table I The dosages quoted are those given at the present time. At the beginning of the work rather lower dosages were given. The radiation dose in rads to the lymph nodes has been estimated by direct measurement up to 100,000 rads. This calculation has been made by using the formula of Hine and Brownell (1956) .
Melanoma Series of Patients
The fifty patients reviewed are subdivided into various groups, as indicated in Tables II and III. The effects of the endolymphatic radiation on the white blood counts are outlined in Table II . regions were those which showed the most frequent and prolonged depression of both lymphocyte counts and leucocyte estimations. An illustrative example is shown in Fig. 3 . In this patient with normal preoperative W.B.C. estimations the endolymphatic infusion after excision of the primary melanoma of the calf was followed by an absolute lymphopenia to the order of 500 cells per cu. mm. at first. It persisted for two months, and later was associated with a mild depression of the total leucocyte value. This was illustrative of many cases treated with lower limb infusions, though few of the patients showed depression beyond one month's duration. Upper-limb infusion, both unilateral and bilateral, did not demonstrate findings to the same degree. As seen from Table II , occasionally absolute lymphopenia did occur, but this was a transitory finding. The histogram (Fig. 4) Lugol's iodine by mouth to prevent thyroid uptake of "" I:
(1) wide excision of primary area and application of skin graft, and bilateral intralymphatic injection to both axillae of "3'I Lipiodol on 22 September 1965 (Fig. 5) ; (2) bilateral intralymphatic injection of lower limbs to the ilioinguinal and para-aortic lymph nodes on 29 September (Fig. 5) ; and (3) block dissection of left axilla on 20 October (see Fig. 6 ). Total dosage of "3'I Lipiodol was: Axillary: 35 mCi in 2 ml. Lipiodol "'Ix2=70 "zCi "'I Ilioinguinal: 40 mCi in 4 ml. Lipiodol 131Ix2=80 mCi "I
The postoperative leucocyte and lymphocyte findings in this patient are shown in Fig. 7 . A prolonged and marked drop in the absolute lymphocyte count that occurred initially was associated in the later phase with a general depression of the leucocyte count. This trend was reversing and the levels after five months were almost back to normal, though still depressed below the preoperative levels. The patient throughout has remained well and was free, clinically, of metastatic disease. In view of the late stage with involved nodes in the left axilla and the multiplicity of drainage sites his prognosis by conventional treatment standards cannot be good and fully warranted the extended therapy actually given. infused, as comparison with the volume of demonstrable lymphoid tissue after bilateral brachial infusions would not be invidious. It is well known that the histological structure of lymph nodes in different areas of the body differs markedly in many respects, and it may well be that they also have different functions. It could be that the para-aortic nodes have a main function of producing lymphocytes for discharge into the general circulation via the thoracic duct; certainly on observing the flow of contrast media through the para-aortic lymph nodes it would appear unlikely that they function purely as filtering mechanisms. Further study would be needed to elucidate this possibility. There is only a suggestion that there may be a difference in function of nodes as sources of blood lymphocytes. The lymphopenia in our patients was greatest when a greater volume of lymph tissue was injected. This applied particularly to the patient whose case is described above, in whom four-quadrant endolymphatic therapy was used.
The procedure of endolymphatic infusion is a relatively simple manceuvre and can be carried out under local anaesthesia. It may well have a place in producing selective lymphopenia in the early stage of tissue transplantation.
Summary
One of the postoperative sequelae of intralymphatic radioisotope infusions is discussed in this paper-namely, the leucocyte findings, with particular attention to selective lymphopenia.
Selective lymphopenia may be attained, particularly after The relevance of these findings to problems of tissue transplantation, in particular graft rejection, is mentioned and discussed. The simplicity of the method of endolymphatic infusion in producing a lymphopenia that may last up to five months makes it a possible alternative to other methods of immunosuppression, particularly in the early phase of tissue transplantation.
forward as an effective treatment for ulcerative colitis which has the great advantage that it causes neither adrenal suppression nor the usual side-effects of steroid therapy (Morton Gill et al., 1965) . A steroid which is not absorbed after oral administration but which is topically active in the large intestine would be a major advance in the treatment of colitis. We have therefore studied the absorption of betamethasone 17-valerate in normal subjects by measuring its effect on adrenal function. In patients with ulcerative colitis we have studied its use as a treatment and correlated the clinical results with studies of adrenal function.
Methods
Heparinized blood samples were collected between 9 and 10 a.m. The plasma was separated within 30 minutes of venepuncture and stored at -4' C. until the estimations were performed. The plasma cortisol was measured as free plasma total 1 1-hydroxycorticosteroids by a modification of the fluorometric method of Mattingly (1962) (Black and Friedman, 1965) . With this method the normal range of plasma cortisol level at 9 a.m. is 8-28 /ug./100 ml.
Studies in Normal Subjects
Studies were carried out on seven normal subjects who were without any previous gastrointestinal symptoms. They were members of the hospital staff, three men and four women, aged 24 to 39 years.
Five studies were performed (Fig. 1) . In the first two each subject took by mouth in divided six-hourly doses for 48 periods (A) 2 mg. daily of dexamethasone and (B) 2 mg. daily of betamethasone free alcohol. In a third study (C) each subject took 2, 4, and 8 mg. daily of betamethasone 17-valerate in divided six-hourly doses for consecutive 48-hour periods. In a fourth study (D) the two subjects in whom adrenal suppression did not occur on 8 mg. daily of betamethasone 17-valerate in the third study (C) were given 12 mg. daily in divided doses six-hourly for 48 hours. In a fifth study (E) three subjects were given 8 mg. daily of betamethasone 17-valerate in divided doses six-hourly for 48 hours. The studies were not carried out in any fixed order and at least a week was allowed to elapse between each one. The plasma cortisol was measured before and after each 48-hour period, the last blood specimen being taken within three hours of the final dose. 
Studies in Patients with Ulcerative Colitis
Twenty-seven outpatients with ulcerative colitis were treated. Preliminary clinical observations were made in 17 patients who were given 4 or 8 mg. of betamethasone 17-valerate daily by mouth in divided doses. Ten further patients were treated with 8 mg. daily for two to four weeks. In these ten patients the clinical results were correlated with plasma cortisol levels measured before treatment, and at two and/or four weeks. The patients were asked to take the tablets four times daily and to ensure that one was taken on the morning of the visit to the clinic. At each attendance they were asked whether any tablets had been missed. No direct inquiry was made about sideeffects. The results of treatment were assessed symptomatically and sigmoidoscopically, as described in previous trials (Baron et al., 1962b) . A remission is defined as complete freedom from symptoms with a non-haemorrhagic non-friable mucosa on sigmoidoscopy.
